drugset / Trial / NCT00334581
Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
RandomizedParallel-groupOpen-labelTreatment
Summary
Primary objective: * To determine if irbesartan 300mg is better than 150mg in protecting the kidneys in hypertensive patients with diabetes and microalbuminuria. Secondary objectives: * To determine how well irbesartan 300mg is tolerated versus 150mg * To determine the percentage of patients reaching the blood pressure target of 130/80 mmHg
Timeline
- Start
- 2006-05
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irbesartan | Small molecule | 150 mg | — |
| Subject | Irbesartan | Small molecule | 300 mg | — |